スポンサーリンク
長崎大学 医歯薬学総合研究科臨床薬学 | 論文
- Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
- 開発メーカーが知っておきたい抗体医薬品(抗リウマチ薬)の有害事象 (特集 抗体医薬品の現在進行形--開発・生産技術・特許範囲)
- 疾患特有の評価法(4)関節リウマチ
- 各疾患における浮腫の機序とアプローチ リウマチ・膠原病疾患 (特集 浮腫を診る)
- 抗リウマチ薬 (生涯教育シリーズ(67)わかりやすい免疫疾患) -- (免疫学的治療法)
- Present status of hepatitis virus-associated hepatocellular carcinoma in Nagasaki Prefecture, Japan : a cross-sectional study of 1019 patients
- Clinical Manifestations of HBsAg and Anti-HCV Negative Chronic Liver Disease in Nagasaki Prefecture, Japan
- The Serum Level of Carcinoembryonic Antigen in Drainage Venous Blood Is Not a Sensitive Predictor of Metachronous Hepatic Metastasis for Patients with Colorectal Cancer
- Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine
- Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
- Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance
- Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1^*shared epitope-negative rheuma
- Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
- Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4
- Emergence of anti-islet autoantibodies in Japanese patients with type 1 diabetes
- First Japanese Patient Treated with Parathyroid Hormone Peptide Immunization for Refractory Hypercalcemia Caused by Metastatic Parathyroid Carcinoma
- A Long-term Follow-up of Serum Myeloperoxidase Antineutrophil Cytoplasmic Antibodies (MPO-ANCA) in Patients with Graves Disease Treated with Propylthiouracil
- In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline
- Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab : comparison with the remission by the clinical disease activity index
- Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review